Full Text View
Tabular View
No Study Results Posted
Related Studies
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)
This study is ongoing, but not recruiting participants.
Study NCT00392054   Information provided by Population Health Research Institute

First Received on October 23, 2006.   Last Updated on July 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atrial Fibrillation
More general conditions related to this trial
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Anti-Arrhythmia Agents
More general drug interventions related to this trial
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Population Health Research Institute
Johnson & Johnson


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services